ArticleBlood2022

Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study.

Mirian Brink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.